DePuy Synthes’ ASC Focus Spurs Knee and Hip Growth

DePuy Synthes reported 1Q22 orthopedic sales of $2.1 billion, +3.5% vs 1Q21.

The first quarter brought a quicker than expected recovery from the omicron trough of November and December. Both the EMEA and Asia Pacific regions had broad-based recoveries. However, DePuy Synthes expects a pandemic-related disruption in China through at least...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us